FDA panel turns down Lifecore adhesion prevention product
This article was originally published in Clinica
Executive Summary
A panel of advisors to the US FDA has voted against approval of an adhesion prevention product made by Lifecore Biomedical, deciding that the clinical trial data did not demonstrate safety and effectiveness. The panel voted five to two against the Intergel solution, which is designed to reduce internal scarring after gynaecological surgery.